Clinical trial

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

NCT04567524

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-08-13

PhasePHASE2

Study timeline

Study start (actual)2020-08-13Date precision: day

Registry last updated2023-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophrenia Schizoaffectiveunresolved

Interventions

LYN-005DRUG

Sponsors & collaborators

Lyndra Inc.lead sponsor

Worldwide Clinical Trialscollaborator

Mapped research locations

AtlantaGeorgia, United States1 AustinTexas, United States1 Long BeachCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04567524 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.